Cetera Investment Advisers’s Phio Pharmaceuticals PHIO Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $76.4K | Sell |
32,500
-6,000
| -16% | -$14.1K | ﹤0.01% | 3921 |
|
2025
Q1 | $50.1K | Buy |
38,500
+25,500
| +196% | +$33.2K | ﹤0.01% | 3855 |
|
2024
Q4 | $23.4K | Buy |
+13,000
| New | +$23.4K | ﹤0.01% | 3693 |
|
2024
Q3 | – | Sell |
-35,416
| Closed | -$24.5K | – | 3825 |
|
2024
Q2 | $24.5K | Buy |
35,416
+5,000
| +16% | +$3.46K | ﹤0.01% | 3634 |
|
2024
Q1 | $20.7K | Buy |
30,416
+13,500
| +80% | +$9.18K | ﹤0.01% | 3624 |
|
2023
Q4 | $12.9K | Buy |
16,916
+6,250
| +59% | +$4.75K | ﹤0.01% | 2200 |
|
2023
Q3 | $16.1K | Hold |
10,666
| – | – | ﹤0.01% | 2161 |
|
2023
Q2 | $30.6K | Buy |
+10,666
| New | +$30.6K | ﹤0.01% | 2139 |
|
2023
Q1 | – | Sell |
-75,000
| Closed | -$27.9K | – | 2201 |
|
2022
Q4 | $27.9K | Hold |
75,000
| – | – | ﹤0.01% | 2055 |
|
2022
Q3 | $43K | Hold |
75,000
| – | – | ﹤0.01% | 1620 |
|
2022
Q2 | $53K | Sell |
75,000
-15,000
| -17% | -$10.6K | ﹤0.01% | 1764 |
|
2022
Q1 | $80K | Buy |
90,000
+50,000
| +125% | +$44.4K | ﹤0.01% | 1817 |
|
2021
Q4 | $40K | Buy |
40,000
+10,000
| +33% | +$10K | ﹤0.01% | 1833 |
|
2021
Q3 | $61K | Buy |
+30,000
| New | +$61K | ﹤0.01% | 1757 |
|